SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,525,000 | -14.2% | 1,268,946 | 0.0% | 0.24% | -14.6% |
| Q4 2019 | $8,768,000 | -33.4% | 1,268,946 | 0.0% | 0.28% | -47.9% |
| Q3 2019 | $13,172,000 | +12.1% | 1,268,946 | 0.0% | 0.54% | +27.3% |
| Q2 2019 | $11,750,000 | +1.3% | 1,268,946 | +0.0% | 0.42% | -5.2% |
| Q1 2019 | $11,598,000 | +64.1% | 1,268,945 | 0.0% | 0.44% | +57.2% |
| Q4 2018 | $7,068,000 | -53.2% | 1,268,945 | 0.0% | 0.28% | -47.7% |
| Q3 2018 | $15,113,000 | +16.6% | 1,268,945 | 0.0% | 0.54% | +18.9% |
| Q2 2018 | $12,956,000 | -21.3% | 1,268,945 | 0.0% | 0.46% | -20.3% |
| Q1 2018 | $16,471,000 | +33.4% | 1,268,945 | 0.0% | 0.57% | +17.5% |
| Q4 2017 | $12,347,000 | -33.9% | 1,268,945 | 0.0% | 0.49% | -42.2% |
| Q3 2017 | $18,679,000 | -8.5% | 1,268,945 | 0.0% | 0.84% | -22.8% |
| Q2 2017 | $20,417,000 | -20.6% | 1,268,945 | -21.4% | 1.09% | +9.8% |
| Q1 2017 | $25,729,000 | +16.7% | 1,615,136 | -10.9% | 0.99% | +9.4% |
| Q4 2016 | $22,043,000 | -12.3% | 1,812,778 | 0.0% | 0.91% | -22.4% |
| Q3 2016 | $25,143,000 | -33.9% | 1,812,778 | -13.5% | 1.17% | -21.8% |
| Q2 2016 | $38,028,000 | – | 2,095,220 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |